TACARYL Drug Patent Profile
✉ Email this page to a colleague
When do Tacaryl patents expire, and when can generic versions of Tacaryl launch?
Tacaryl is a drug marketed by Westwood Squibb and is included in one NDA.
The generic ingredient in TACARYL is methdilazine. There are two drug master file entries for this compound. Additional details are available on the methdilazine profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TACARYL?
- What are the global sales for TACARYL?
- What is Average Wholesale Price for TACARYL?
Summary for TACARYL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 22 |
| Patent Applications: | 2,676 |
| DailyMed Link: | TACARYL at DailyMed |
US Patents and Regulatory Information for TACARYL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Westwood Squibb | TACARYL | methdilazine hydrochloride | SYRUP;ORAL | 011950-007 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Westwood Squibb | TACARYL | methdilazine | TABLET, CHEWABLE;ORAL | 011950-009 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Westwood Squibb | TACARYL | methdilazine hydrochloride | TABLET;ORAL | 011950-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
